October 7, 2026
Biotechnology’s New Frontier: NSCEB Showcases Huntsville’s Role in National Security and Agricultural Resilience biotechnologys-new-frontier-nsceb-showcases-huntsvilles-role-in-national-security-and-agricultural-resilience

Biotechnology’s New Frontier: NSCEB Showcases Huntsville’s Role in National Security and Agricultural Resilience

Siti Muinah May 8, 2026 0
HUNTSVILLE, ALABAMA – In a significant move to bridge the gap between cutting-edge laboratory research and national...
Read More Read more about Biotechnology’s New Frontier: NSCEB Showcases Huntsville’s Role in National Security and Agricultural Resilience
A Trojan Horse in the War on Cancer: Mount Sinai Scientists Redefine Immunotherapy by Targeting Tumor Defenses a-trojan-horse-in-the-war-on-cancer-mount-sinai-scientists-redefine-immunotherapy-by-targeting-tumor-defenses

A Trojan Horse in the War on Cancer: Mount Sinai Scientists Redefine Immunotherapy by Targeting Tumor Defenses

Nana May 8, 2026 0
NEW YORK, NY – January 22, 2024 – In a significant paradigm shift for cancer treatment, scientists...
Read More Read more about A Trojan Horse in the War on Cancer: Mount Sinai Scientists Redefine Immunotherapy by Targeting Tumor Defenses
Bridging the Gap: Bionews Launches "The Rare Journey" to Revolutionize Patient Storytelling in Rare Disease Care bridging-the-gap-bionews-launches-the-rare-journey-to-revolutionize-patient-storytelling-in-rare-disease-care

Bridging the Gap: Bionews Launches "The Rare Journey" to Revolutionize Patient Storytelling in Rare Disease Care

Iffa Jayyana May 8, 2026 0
PENSACOLA, Florida — August 19, 2024 — For the millions of individuals navigating the labyrinthine world of...
Read More Read more about Bridging the Gap: Bionews Launches "The Rare Journey" to Revolutionize Patient Storytelling in Rare Disease Care
Rivanna’s Accuro XV Secures FDA Clearance: A New Frontier in Point-of-Care Musculoskeletal Imaging rivannas-accuro-xv-secures-fda-clearance-a-new-frontier-in-point-of-care-musculoskeletal-imaging

Rivanna’s Accuro XV Secures FDA Clearance: A New Frontier in Point-of-Care Musculoskeletal Imaging

Ammar Sabilarrohman May 8, 2026 0
In a major milestone for point-of-care diagnostics, Virginia-based medical technology innovator Rivanna has received US Food and...
Read More Read more about Rivanna’s Accuro XV Secures FDA Clearance: A New Frontier in Point-of-Care Musculoskeletal Imaging
The Silent Pandemic: Global Progress and Persistent Gaps in the Fight Against Viral Hepatitis the-silent-pandemic-global-progress-and-persistent-gaps-in-the-fight-against-viral-hepatitis

The Silent Pandemic: Global Progress and Persistent Gaps in the Fight Against Viral Hepatitis

Ali Ikhwan May 8, 2026 0
By Global Health Correspondent Despite significant strides in medical innovation and public health policy, viral hepatitis remains...
Read More Read more about The Silent Pandemic: Global Progress and Persistent Gaps in the Fight Against Viral Hepatitis

You may have missed

unveiling-a-cunning-cancer-strategy-how-triple-negative-breast-cancer-recruits-nerves-for-growth-and-survival

Unveiling a Cunning Cancer Strategy: How Triple-Negative Breast Cancer Recruits Nerves for Growth and Survival

Iffa Jayyana October 7, 2026
arrivents-firmonertinib-fails-to-meet-primary-endpoint-in-nsclc-trial-stock-plummets-amidst-competitive-landscape

ArriVent’s Firmonertinib Fails to Meet Primary Endpoint in NSCLC Trial, Stock Plummets Amidst Competitive Landscape

Muslim October 7, 2026
navigating-the-intersection-glp-1-medications-and-breast-cancer-what-the-latest-research-reveals

Navigating the Intersection: GLP-1 Medications and Breast Cancer – What the Latest Research Reveals

Ammar Sabilarrohman October 7, 2026
research-as-the-cure-bcrf-transforms-grand-central-terminal-into-a-hub-of-hope-and-science

Research as the Cure: BCRF Transforms Grand Central Terminal into a Hub of Hope and Science

Siti Muinah October 7, 2026